The comparative characteristic of influence separate statin on rheological properties erythrocyre at sick of the arterial hypertension with dyslipidemia

The purpose - comparative investigation of influence of inhibitors hydroxy-methyllglutaril co-enzyme A-reductase - Fluvastatin, Lovastatin and Simvastatin on rheological properties of erythrocytes in patients with arterial hypertension and dyslipidemia. The total number of enrolled patients was 95 a...

Full description

Bibliographic Details
Main Authors: I N Medvedev, I А Skorjatina
Format: Article
Language:English
Published: Peoples’ Friendship University of Russia (RUDN University) 2011-03-01
Series:RUDN Journal of Medicine
Subjects:
Online Access:http://journals.rudn.ru/medicine/article/view/3470
id doaj-11fc4e5834e64fdcb07154034df2bae6
record_format Article
spelling doaj-11fc4e5834e64fdcb07154034df2bae62020-11-24T22:36:37ZengPeoples’ Friendship University of Russia (RUDN University)RUDN Journal of Medicine2313-02452313-02612011-03-010158653470The comparative characteristic of influence separate statin on rheological properties erythrocyre at sick of the arterial hypertension with dyslipidemiaI N Medvedev0I А Skorjatina1Курский институт социального образования(филиал) РГСУКурский институт социального образования(филиал) РГСУThe purpose - comparative investigation of influence of inhibitors hydroxy-methyllglutaril co-enzyme A-reductase - Fluvastatin, Lovastatin and Simvastatin on rheological properties of erythrocytes in patients with arterial hypertension and dyslipidemia. The total number of enrolled patients was 95 and all of them had arterial hypertension 1-2 degrees, risk 3 and dyslipidemia II type (recommendation VNOK, 2007). The average age of patients was 52,4 ± 2,6 yrs. The control group included 26 healthy people of similar age. Patients have been divided into 3 comparable, homogeneous groups according to administration either Fluvastatin or Lovastatin or Simvastatin for 12 months in each group. Administration of Fluvastatin and Lovastatin in patients with arterial hypertension with dyslipidemia within 1 year is capable to reduce activity lipid oxidations of lipids in erythrocyte membranes, its deformation changes and aggregation activity whereas the therapy by Simvastatin allows the erythrocyte activity to reach the values in control group.http://journals.rudn.ru/medicine/article/view/3470флувастатинловастатинсимвастатин
collection DOAJ
language English
format Article
sources DOAJ
author I N Medvedev
I А Skorjatina
spellingShingle I N Medvedev
I А Skorjatina
The comparative characteristic of influence separate statin on rheological properties erythrocyre at sick of the arterial hypertension with dyslipidemia
RUDN Journal of Medicine
флувастатин
ловастатин
симвастатин
author_facet I N Medvedev
I А Skorjatina
author_sort I N Medvedev
title The comparative characteristic of influence separate statin on rheological properties erythrocyre at sick of the arterial hypertension with dyslipidemia
title_short The comparative characteristic of influence separate statin on rheological properties erythrocyre at sick of the arterial hypertension with dyslipidemia
title_full The comparative characteristic of influence separate statin on rheological properties erythrocyre at sick of the arterial hypertension with dyslipidemia
title_fullStr The comparative characteristic of influence separate statin on rheological properties erythrocyre at sick of the arterial hypertension with dyslipidemia
title_full_unstemmed The comparative characteristic of influence separate statin on rheological properties erythrocyre at sick of the arterial hypertension with dyslipidemia
title_sort comparative characteristic of influence separate statin on rheological properties erythrocyre at sick of the arterial hypertension with dyslipidemia
publisher Peoples’ Friendship University of Russia (RUDN University)
series RUDN Journal of Medicine
issn 2313-0245
2313-0261
publishDate 2011-03-01
description The purpose - comparative investigation of influence of inhibitors hydroxy-methyllglutaril co-enzyme A-reductase - Fluvastatin, Lovastatin and Simvastatin on rheological properties of erythrocytes in patients with arterial hypertension and dyslipidemia. The total number of enrolled patients was 95 and all of them had arterial hypertension 1-2 degrees, risk 3 and dyslipidemia II type (recommendation VNOK, 2007). The average age of patients was 52,4 ± 2,6 yrs. The control group included 26 healthy people of similar age. Patients have been divided into 3 comparable, homogeneous groups according to administration either Fluvastatin or Lovastatin or Simvastatin for 12 months in each group. Administration of Fluvastatin and Lovastatin in patients with arterial hypertension with dyslipidemia within 1 year is capable to reduce activity lipid oxidations of lipids in erythrocyte membranes, its deformation changes and aggregation activity whereas the therapy by Simvastatin allows the erythrocyte activity to reach the values in control group.
topic флувастатин
ловастатин
симвастатин
url http://journals.rudn.ru/medicine/article/view/3470
work_keys_str_mv AT inmedvedev thecomparativecharacteristicofinfluenceseparatestatinonrheologicalpropertieserythrocyreatsickofthearterialhypertensionwithdyslipidemia
AT iaskorjatina thecomparativecharacteristicofinfluenceseparatestatinonrheologicalpropertieserythrocyreatsickofthearterialhypertensionwithdyslipidemia
AT inmedvedev comparativecharacteristicofinfluenceseparatestatinonrheologicalpropertieserythrocyreatsickofthearterialhypertensionwithdyslipidemia
AT iaskorjatina comparativecharacteristicofinfluenceseparatestatinonrheologicalpropertieserythrocyreatsickofthearterialhypertensionwithdyslipidemia
_version_ 1725719297197604864